Skip to main content

Hypoplastic Left Heart Syndrome clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for
  • National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

    open to eligible people ages up to 15 months

    The purpose of this initiative is to improve care and outcomes for infants with HLHS by expanding the NPC-QIC national registry to gather clinical care process, outcome, and developmental data on infants with HLHS between diagnosis and 12 months of age, by improving the use of standards into everyday practice across pediatric cardiology centers, and by engaging parents as partners in the process.

    at UC Davis UCLA

  • Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome

    Sorry, in progress, not accepting new patients

    For fetuses with severe aortic stenosis, in utero balloon aortic valvuloplasty may improve fetal growth of left heart structures and thus improve potential for biventricular repair strategies after birth.

    at UCSF

Our lead scientists for Hypoplastic Left Heart Syndrome research studies include .

Last updated: